Novo Nordisk

Top insulin maker Novo caught up in China's widening drug probes
Yahoo/Reuters
Thu, 08/8/13 - 08:59 am
Novo Nordisk
China
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
Seeking Alpha
Tue, 08/6/13 - 10:49 am
Rexahn
Merck
Novo Nordisk
Teva
Archexin
cancer
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Bloomberg
Fri, 07/26/13 - 09:03 am
diabetes
Europe
Byetta
Bristol-Myers Squibb
Merck
Januvia
GLP-1 agonist
Novo Nordisk
Victoza
Novo Nordisk: A Pure Play In The Large And Lucrative Diabetes Care Sector
Seeking Alpha
Tue, 07/23/13 - 11:14 am
Novo Nordisk
diabetes
MannKind
Merck
The Future of Sanofi's Insulin Empire
Motley Fool
Fri, 07/19/13 - 10:17 am
Sanofi
insulin
Eli Lilly
Novo Nordisk
diabetes
U300
Lantus
LixiLan
Sun Pharma gets USFDA nod for generic diabetes tablets
Zee News, India
Sat, 07/13/13 - 12:43 pm
Sun Pharma
diabetes
repaglinide
Prandin
Novo Nordisk
generics
China's Coming Big Pharma Boom
Motley Fool
Wed, 07/10/13 - 11:07 am
China
Big Pharma
Merck
Novo Nordisk
Bayer
Pfizer
Teva
Merck's $5.7 Billion Diabetes Franchise Is Vulnerable
Seeking Alpha
Wed, 07/10/13 - 10:25 am
Merck
diabetes
Novo Nordisk
Eli Lilly
Novartis
Januvia
Dissecting the World's Biggest Diabetes Drug Stock
Motley Fool
Sat, 07/6/13 - 11:56 am
Novo Nordisk
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Novo Nordisk
diabetes
Eli Lilly
GLP-1 agonist
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Victoza
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thu, 06/27/13 - 08:55 pm
Eli Lilly
diabetes
dulaglutide
JNJ
Merck
Novo Nordisk
Bristol-Myers Squibb
Novo Nordisk Suspends Paula Deen As A Spokesperson
Pharmalot
Thu, 06/27/13 - 11:15 am
Novo Nordisk
Paula Deen
diabetes
New AMA Obesity Ruling Should Push Big Pharma To Find Acquisitions
Seeking Alpha
Thu, 06/27/13 - 09:59 am
obesity
M&A
Oramed
AstraZeneca
MannKind
Merck
Sanofi
Novo Nordisk
New GSK diabetes drug works, but faces tough competition
Reuters
Mon, 06/24/13 - 10:28 am
GSK
diabetes
albiglutide
GLP-1 agonist
Victoza
Byetta
Bydureon
Novo Nordisk
Bristol-Myers Squibb
AstraZeneca
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Fri, 06/21/13 - 09:26 am
diabetes
Merck
Januvia
Lantus
Sanofi
NovoRapid
Novo Nordisk
Eli Lilly
Humalog
Victoza
Levemir
Janumet
Novo Mix 30
Takeda
Actos
Novo Nordisk shares hit by concerns over rival diabetes drugs
Reuters
Mon, 06/17/13 - 09:17 am
diabetes
Novo Nordisk
Sanofi
Eli Lilly
dulaglutide
Victoza
Lyxumia
Lantus
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim
Novo Nordisk Is An Undervalued Industry Leading Healthcare Company
Seeking Alpha
Wed, 06/12/13 - 08:53 am
Novo Nordisk
Sanofi steps up diabetes drive as rivals raise the stakes
Reuters
Fri, 06/7/13 - 09:18 am
Sanofi
diabetes
Novo Nordisk

Pages